ERIS / NSE / Biotechnology & Drugs
Eris Lifesciences
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High1,909.55
Target Low1,237.9
Target Mean1.6
Target Median75
Risk Metrics
Overall RiskBalanced risk
Board Risk35.78
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
ERIS Lifesciences Ltd Valuation Shifts Signal Changing Market Sentiment Markets Mojo
Eris Lifesciences - Ipca Laboratories among 5 stocks showing bullish RSI upswing The Economic Times
ERIS Lifesciences Ltd is Rated Hold Markets Mojo
Eris Lifesciences - JSW Dulux among 4 stocks flashing bullish signals, hinting at a possible uptrend The Economic Times
Eris Lifesciences fined ₹4.24 lakh for board composition lapse scanx.trade
Eris promoters confirm no encumbrance on 53.92% stake scanx.trade
Eris Lifesciences posts analyst call transcript for Q4FY26 scanx.trade
Eris Lifesciences to meet Franklin Templeton on May 29 scanx.trade
© SharekeyX | Rusaka Technologies 2024-2026

